End-of-day quote
Korea S.E.
04:30:00 22/03/2022 am IST
|
5-day change
|
1st Jan Change
|
34,800
KRW
|
+2.65%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
46,869
|
60,612
|
1,70,031
|
1,45,492
|
2,05,818
|
2,05,818
|
Enterprise Value (EV)
1 |
59,444
|
95,115
|
1,62,076
|
1,22,694
|
2,02,158
|
2,06,030
|
P/E ratio
|
-1.97
x
|
-2.24
x
|
15.9
x
|
-1.46
x
|
-3.04
x
|
-11.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.77
x
|
6.46
x
|
6.77
x
|
8.01
x
|
22.6
x
|
102
x
|
EV / Revenue
|
8.59
x
|
10.1
x
|
6.45
x
|
6.76
x
|
22.2
x
|
102
x
|
EV / EBITDA
|
-10.2
x
|
-13.2
x
|
-49.8
x
|
-2.87
x
|
-5.79
x
|
-15.8
x
|
EV / FCF
|
-5.88
x
|
-10.6
x
|
-7.47
x
|
-7.26
x
|
-29.1
x
|
-154
x
|
FCF Yield
|
-17%
|
-9.43%
|
-13.4%
|
-13.8%
|
-3.43%
|
-0.65%
|
Price to Book
|
2.25
x
|
2.48
x
|
2.26
x
|
3.85
x
|
-28.1
x
|
219
x
|
Nbr of stocks (in thousands)
|
1,379
|
2,228
|
3,909
|
5,914
|
5,914
|
5,914
|
Reference price
2 |
34,000
|
27,200
|
43,500
|
24,600
|
34,800
|
34,800
|
Announcement Date
|
13/03/19
|
19/03/20
|
18/03/21
|
22/03/22
|
21/03/23
|
08/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,919
|
9,388
|
25,110
|
18,153
|
9,089
|
2,023
|
EBITDA
1 |
-5,802
|
-7,203
|
-3,254
|
-42,773
|
-34,909
|
-13,053
|
EBIT
1 |
-6,556
|
-7,691
|
-3,747
|
-43,462
|
-36,068
|
-14,028
|
Operating Margin
|
-94.76%
|
-81.92%
|
-14.92%
|
-239.43%
|
-396.83%
|
-693.57%
|
Earnings before Tax (EBT)
1 |
-9,604
|
-24,443
|
7,947
|
-74,763
|
-38,285
|
-17,763
|
Net income
1 |
-20,440
|
-25,409
|
7,979
|
-74,763
|
-38,285
|
-17,763
|
Net margin
|
-295.44%
|
-270.66%
|
31.77%
|
-411.85%
|
-421.23%
|
-878.24%
|
EPS
2 |
-17,236
|
-12,160
|
2,740
|
-16,834
|
-11,440
|
-3,003
|
Free Cash Flow
1 |
-10,103
|
-8,966
|
-21,706
|
-16,903
|
-6,944
|
-1,337
|
FCF margin
|
-146.03%
|
-95.51%
|
-86.44%
|
-93.11%
|
-76.4%
|
-66.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/03/19
|
19/03/20
|
18/03/21
|
22/03/22
|
21/03/23
|
08/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
12,574
|
34,503
|
-
|
-
|
-
|
211
|
Net Cash position
1 |
-
|
-
|
7,955
|
22,799
|
3,660
|
-
|
Leverage (Debt/EBITDA)
|
-2.167
x
|
-4.79
x
|
-
|
-
|
-
|
-0.0162
x
|
Free Cash Flow
1 |
-10,103
|
-8,966
|
-21,706
|
-16,903
|
-6,944
|
-1,337
|
ROE (net income / shareholders' equity)
|
-51.5%
|
-105%
|
16%
|
-148%
|
-251%
|
-179%
|
ROA (Net income/ Total Assets)
|
-9.59%
|
-8.59%
|
-3.06%
|
-37%
|
-55.4%
|
-49.1%
|
Assets
1 |
2,13,190
|
2,95,689
|
-2,60,633
|
2,02,115
|
69,073
|
36,159
|
Book Value Per Share
2 |
15,112
|
10,969
|
19,287
|
6,397
|
-1,238
|
159.0
|
Cash Flow per Share
2 |
2,364
|
2,222
|
1,926
|
2,263
|
432.0
|
37.10
|
Capex
1 |
1,068
|
1,007
|
85.1
|
10,987
|
1,331
|
47.9
|
Capex / Sales
|
15.43%
|
10.73%
|
0.34%
|
60.52%
|
14.65%
|
2.37%
|
Announcement Date
|
13/03/19
|
19/03/20
|
18/03/21
|
22/03/22
|
21/03/23
|
08/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 616M | | -15.08% | 8.21B | | -1.35% | 1.39B | | +2.39% | 1.27B | | -32.82% | 702M | | +10.62% | 486M | | +1.70% | 430M | | -36.77% | 281M | | -68.78% | 224M | | +1.42% | 218M |
Medical Equipment Wholesale
|